Sebetralstat — Drug Intelligence | 2 EU Trials

Filter these 2 trials by condition, phase, country and more.

2 Registered trials

0 Recruiting

2 Completed trials

1 Sponsors

13 Countries

Phase III

Phase III: 2

Sponsors using this IMP

2 total

KONFIDENT-KID Ended

2023-507591-44-00 Phase III 3 countries Kalvista Pharmaceuticals Limited
A long-term study to evaluate if KVD900 is safe and effective in treating attacks in patients with Hereditary Angioedema. Ended

2023-505904-41-00 Phase III 13 countries Kalvista Pharmaceuticals Limited

Showing 1–2 of 2 trials